Is REGN a good stock to buy? We came across a bullish thesis on Regeneron Pharmaceuticals, Inc. on r/investing_discussion by Variant_Invest. In this article, we will summarize the bulls’ thesis on REGN. Regeneron Pharmaceuticals, Inc.’s share was trading at $616.18 as of June 9th. REGN’s trailing and forward P/E were 15.51 and 14.16 respectively according to Yahoo Finance.
Pressmaster/Shutterstock.com
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and...
